BiotechTube

Docetaxel + Erlotinib + Chemotherapy

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Head and Neck Cancer

Conditions

Head and Neck Cancer

Trial Timeline

Dec 16, 2013 → Jan 6, 2025

NCT ID
NCT01927744

About Docetaxel + Erlotinib + Chemotherapy

Docetaxel + Erlotinib + Chemotherapy is a phase 2 stage product being developed by Astellas Pharma for Head and Neck Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT01927744. Target conditions include Head and Neck Cancer.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT01927744Phase 2Completed

Competing Products

20 competing products in Head and Neck Cancer

See all competitors
ProductCompanyStageHype Score
AFM24 + SNK01AffimedPhase 1/2
33
Cemiplimab + CetuximabEli LillyPhase 2
52
BB-401Benitec BiopharmaPhase 2
44
Placebo + LY2300559Eli LillyPhase 2
52
Gemcitabine + ACR-368Acrivon TherapeuticsPhase 2
44
Ketorolac + Prochlorperazine + DiphenhydramineAssertio HoldingsPhase 2
44
Ramucirumab + PembrolizumabEli LillyPhase 2
52
Ozuriftamab Vedotin + Pembrolizumab + Evalstotug (BA3071) + CetuximabBioAtlaPhase 2
44
Patritumab + Cetuximab + Cisplatin + Carboplatin + PlaceboDaiichi SankyoPhase 2
52
Patritumab + Cetuximab + Cisplatin + CarboplatinDaiichi SankyoPhase 1
33
cevimeline hydrochlorideDaiichi SankyoPhase 3
77
ErlotinibAstellas PharmaPhase 1
33
avelumab + Bempegaldesleukin + talazoparib + enzalutamideAstellas PharmaPhase 1/2
41
Ivermectin Lotion, 0.5% + SKLICE (ivermectin) Lotion, 0.5% + Vehicle of the Test productSun PharmaceuticalPhase 1
33
Drug Combination TherapySun PharmaceuticalPhase 2
52
Lenvatinib + Pembrolizumab + Docetaxel + Capecitabine + Paclitaxel + Cetuximab + LenvatinibEisaiPhase 2
52
E7050 + CetuximabEisaiPhase 1/2
41
Lenvatinib + Pembrolizumab + PlaceboEisaiPhase 3
77
Lenvatinib + Pembrolizumab + PlaceboEisaiPhase 3
77
Aricept (donepezil hydrochloride)EisaiPhase 2
52

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85